Sophie Pierce is determined to make the most of her life - however long she may have.

Stockard has completed the interview portion of the competition and is now preparing for on-stage competition, which, for her, begins Wednesday.

KIT-2014 is under development for the treatment of cystic fibrosis, chronic obstructive pulmonary disease and asthma. The therapeutic candidate acts by targeting phosphoinositide 3-kinase gamma. It is ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

There was severe flooding in the Mid-Ohio Valley at the beginning of April that caused some businesses to go underwater. Two ...

Inogen, Inc. INGN recently announced the FDA 510 (k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is ...

Giving back to the community is also a cornerstone of his life, as he actively supports organizations like the Cystic Fibrosis Foundation and the Make-A-Wish Foundation. "Helping others reminds me of ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for ...

Sixteen-year-old Kaia Barret lays in a hospital bed for the third day in a row after suffering intense burns and<a ...

PROVIDENCE, R.I. (WLNE) — The Rhode Island General Assembly is turning out a bevy of new laws for 2025. Starting Wednesday, ...

Each child had already undergone at least three open-heart surgeries. They'd endured countless hours in doctors' offices and ...